Arsil%2525252525252525252525252525252525252525252525252525252520dx

# Arsil-DX (Dextromethorphan Hydrobromide/Chlorpheniramine Maleate) ## Overview Arsil-DX is a combination cough and cold product containing an antitussive (dextromethorphan) and a first-generation antihistamine (chlorpheniramine). It is intended for symptomatic relief of upper respiratory symptoms. ## Primary Indications Symptomatic relief of cough due to minor throat and bronchial irritation and temporary relief of runny nose and sneezing associated with the common cold or allergic rhinitis. ## Adult Dosing * **Standard Dose:** 10 mL to 20 mL of syrup (or equivalent formulation) every 4 to 6 hours. * **Maximum Dose:** Do not exceed 80 mL in a 24-hour period. ## Pediatric Dosing **Note:** Use of OTC cough and cold products in children under 6 years old is generally discouraged due to lack of efficacy and safety concerns. * **Children 6 to 12 years:** 5 mL to 10 mL every 4 to 6 hours. Maximum: 40 mL/24 hours. * **Children under 6 years:** Consult a pediatrician. Do not use without directed medical oversight. ## Dose Adjustments * **Renal/Hepatic Impairment:** No standard adjustment guidelines; use with caution. Reduced frequency may be warranted in severe impairment due to diminished clearance of chlorpheniramine. * **Geriatric:** Increased risk of anticholinergic side effects (urinary retention, sedation, confusion). Start at the lowest end of the dosing range. ## Contraindications * Hypersensitivity to dextromethorphan or chlorpheniramine. * Concomitant use of monoamine oxidase inhibitors (MAOIs) or within 14 days of MAOI discontinuation (risk of serotonin syndrome). * Narrow-angle glaucoma, symptomatic prostatic hypertrophy, or bladder neck obstruction (due to antihistamine effects). ## Adverse Effects * **CNS:** Sedation, drowsiness, dizziness, insomnia (paradoxical). * **Anticholinergic:** Dry mouth, blurred vision, urinary retention, constipation. * **GI:** Nausea, abdominal discomfort. ## Key Drug Interactions * **MAOIs:** Absolute contraindication (hypertensive crisis/serotonin syndrome). * **CNS Depressants:** Alcohol, sedatives, or tranquilizers may significantly potentiate sedative effects. * **CYP2D6 Inhibitors:** May increase plasma concentrations of dextromethorphan. ## Monitoring * Monitor for excessive sedation or respiratory depression. * Monitor for signs of urinary retention, especially in older adults. * Assess symptom progression; if a cough persists for more than 7 days or is accompanied by high fever, rash, or persistent headache, evaluate for underlying pathology. ## Clinical Pearls * **Anticholinergic Burden:** Chlorpheniramine's anticholinergic profile makes it a "potentially inappropriate medication" for elderly patients under Beers Criteria. * **Abuse Potential:** Dextromethorphan has a potential for abuse at supra-therapeutic doses. * **Lack of Efficacy:** Evidence supporting the efficacy of OTC cough suppressants in acute cough is limited. Focus on hydration and humidification as primary adjuncts. *** *Disclaimer: This information is for educational purposes only. Clinical practice guidelines and drug availability vary by region. Always verify specific dosing, safety precautions, and regional restrictions via official prescribing information or a current drug database prior to administration.*